Press Releases

GMV’s research campus is applying robotics and precision medicine to take on the battle against oligometastatic cancer

The DALEM project is an example of space technology transfer to dermatology and public-private collaboration between the Biomedical Research Foundation of Madrid's Hospital Universitario La Paz (FIBHULP) and GMV

This mobile application will make it possible to record the evolution of skin moles that the specialist can examine in a medical check-up

Self-scanning with a cell phone will make it possible to detect melanomas at an early stage, thus helping to reduce morbidity and mortality rates

The public-private consortium includes 17 entities and has received the highest score of all projects submitted in the R&D Missions in Artificial Intelligence competition

The project has a budget of over €7.5 million, funded through the European Union with Next Generation EU funds

The OPTIMA project aims to advance treatments for prostate, breast and lung cancer by applying cutting-edge technologies

The HARMONY Alliance, comprised of the IMI HARMONY and HARMONY PLUS projects, covers the full spectrum of research into hematologic neoplasms and seeks to facilitate the development of more effective treatments for patients affected by this type of disease

The Alliance is applying advanced analytical technologies, big data and artificial intelligence, developed by GMV, to draw the first European map of blood tumors

The HARMONY database will use the data shared to date and aims to function as a tool for designing new clinical tests and reduce their costs, with the corresponding benefits to society

Según conclusiones extraídas en el marco del proyecto de investigación impulsado por el EIT Health, FACET, que cuenta con financiación europea y el liderazgo clínico del Servicio de Geriatría del Hospital Universitario de Getafe

Personas mayores con diagnóstico de fragilidad han sido monitorizadas de forma remota y continua en su domicilio por especialistas de los hospitales públicos de Getafe y Albacete

The objective of the project is to boost safety assessment in the development of new drugs by legacy data sharing

GMV is developing advanced data-integration infrastructure under open standards

It is identified as a “Key Innovator” on the strength of its developments in natural deformation and handling of medical images

GMV’s inhouse development uTile now makes it possible for information on cancer patients to be shared without jeopardizing their privacy during research into new drugs and treatment

Hospitals, research centers and the pharmaceutical industry can now strike the right balance between harnessing healthcare data and respecting patient privacy, without exposing patient data to any risk of disclosure or even moving it from the respective health center

Apex hails the firm as an innovating company on the strength of its radiosurgery planner Radiance™

The worldwide intraoperative radiation therapy market, growing at a rate of 7% from 2019 a 2024, will be worth 67.8 million dollars by the end of that period